FAQ on Quantum BioPharma Ltd.'s PR and Investor Awareness Initiatives

What is the main purpose of Quantum BioPharma Ltd.’s engagement with Enterprise Canada Inc. and Empire Market Ventures, LLC?

Quantum BioPharma Ltd. has engaged Enterprise Canada Inc. to develop its media strategy and Empire Market Ventures, LLC for investor marketing and outreach, aiming to enhance its public relations and investor awareness efforts.

What are the key products mentioned in the content?

The key products mentioned include unbuzzd, a rapid alcohol detoxification beverage; rekvry, an alcohol misuse treatment; and LUCID-21-302, a potential multiple sclerosis treatment moving toward Phase 2 trials.

When is unbuzzd expected to be available?

Unbuzzd is set for availability in Q1 2025.

What is the significance of LUCID-21-302?

LUCID-21-302 is significant as it is a potential treatment for multiple sclerosis, shown to prevent and reverse myelin degradation in preclinical models, and is moving toward Phase 2 trials.

How does Quantum BioPharma Ltd. benefit from its agreement with Celly Nutrition Corp.?

Quantum BioPharma Ltd. retains a 25.71% ownership in Celly Nutrition Corp. and receives royalty payments of 7% of sales from unbuzzd until payments total $250 million, after which the royalty drops to 3% in perpetuity.

Where can investors find the latest news and updates about Quantum BioPharma Ltd.?

The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM.

What is the focus of Quantum BioPharma Ltd.’s subsidiary, Lucid Psycheceuticals Inc.?

Lucid Psycheceuticals Inc. is focused on the research and development of Lucid-MS, a patented new chemical entity for the treatment of multiple sclerosis.

What is the duration of Empire Market Ventures, LLC’s engagement with Quantum BioPharma Ltd.?

Empire Market Ventures, LLC is engaged for three months starting Feb. 7, 2025, to focus on investor marketing and outreach.

What does Quantum BioPharma Ltd. retain in terms of rights for products like unbuzzd?

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.